ArticleChemical biology & drug design2021

Design and synthesis of isothiocyanate-containing hybrid androgen receptor (AR) antagonist to downregulate AR and induce ferroptosis in GSH-Deficient prostate cancer cells.

Zhihui Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.